The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crumpacker, D. B.
Right arrow Articles by Engelhard, V. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crumpacker, D. B.
Right arrow Articles by Engelhard, V. H.

The Journal of Immunology, Vol 148, Issue 10 3004-3011, Copyright © 1992 by American Association of Immunologists


ARTICLES

Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2

DB Crumpacker, J Alexander, P Cresswell and VH Engelhard
Department of Microbiology, University of Virginia, Charlottesville 22908.

One model to explain the high frequency of alloreactive T cells proposes that allogeneic MHC molecules are recognized together with host cell-derived peptides. A model system was developed to investigate the relevance of this mechanism by expression of H-2Dd or H-2Ld in 174xCEM.T2 (T2) cells. This human cell line contains a mutation in its Ag-processing pathway that should restrict the association of endogenous peptides with cell surface class I molecules. CTL generated by stimulating C57BL/6 (H-2b) responder cells with H-2Dd or H-2Ld transfectants of the human B cell line C1R or the murine T cell lymphoma EL4 were assayed for their ability to recognize alloantigenic determinants on these transfectants. The major fraction of the H-2Dd- specific allogeneic CTL response, generated in a MLC or under clonal limiting dilution conditions, was composed of T cells that recognized H- 2Dd expressed on C1R or EL4 cells, but failed to recognize this molecule on T2 cells. Clonal analysis indicated that approximately one- third of these CTL recognized determinants that were unique to H-2Dd expressed on C1R stimulator cells whereas the remainder recognized determinants that were also found on EL4 transfectants. Less than 10% of H-2Dd-reactive CTL recognized the T2 transfectant, and these clones also killed C1R-Dd and EL4-Dd. This result suggests that the great majority of H-2Dd-specific alloreactive CTL recognize determinants that are formed by a complex of H-2Dd with endogenous peptides that are absent or significantly reduced in T2 cells. Based on recognition of human or murine transfectants, these CTL exhibit some level of specificity for the structure or composition of the bound peptides. Examination of allogeneic CTL specific for H-2Ld revealed populations similar to those described for H-2Dd. In addition, a major new population was present that recognized determinants shared between C1R- Ld and T2-Ld but not present on EL4-Ld. These results are consistent with the idea that the alloreactive response to H-2Ld is also largely dependent on the presence of bound peptide. However, they also may indicate that the H-2Ld molecule expressed on T2 cells is occupied by one or more peptides that are shared with other human, but not murine, cells. The significance of these results to current models of alloreactivity is discussed.


This article has been cited by other articles:


Home page
BloodHome page
C. Matte-Martone, J. Liu, D. Jain, J. McNiff, and W. D. Shlomchik
CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL
Blood, April 1, 2008; 111(7): 3884 - 3892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Samino, D. Lopez, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val
A Long N-terminal-extended Nested Set of Abundant and Antigenic Major Histocompatibility Complex Class I Natural Ligands from HIV Envelope Protein
J. Biol. Chem., March 10, 2006; 281(10): 6358 - 6365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. E. Whitelegg, L. E. M. Oosten, S. Jordan, M. Kester, A. G. S. van Halteren, J. A. Madrigal, E. Goulmy, and L. D. Barber
Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers
J. Immunol., August 1, 2005; 175(3): 1706 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond
Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge
J. Immunol., October 15, 2003; 171(8): 4028 - 4039.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val
HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope
J. Immunol., October 15, 2001; 167(8): 4238 - 4244.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Rodriguez, M. K. Slifka, S. Harkins, and J. L. Whitton
Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+ T-Cell Populations with Differing Cytolytic Activities
J. Virol., August 15, 2001; 75(16): 7399 - 7409.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Moris, D. Wernet, S. Stevanovic, and H.-G. Rammensee
The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205-anti-HLA-A*0201 pairings
Int. Immunol., July 1, 2001; 13(7): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Moris, V. Teichgraber, L. Gauthier, H.-J. Buhring, and H.-G. Rammensee
Cutting Edge: Characterization of Allorestricted and Peptide-Selective Alloreactive T Cells Using HLA-Tetramer Selection
J. Immunol., April 15, 2001; 166(8): 4818 - 4821.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. L. Rosa, R. Krishnan, S. Markel, J. P. Schneck, R. Houghten, C. Pinilla, and D. J. Diamond
Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries
Blood, March 15, 2001; 97(6): 1776 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Tsujimura, Y. Obata, S. Iwase, Y. Matsudaira, S. Ozeki, and T. Takahashi
The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent
Int. Immunol., September 1, 2000; 12(9): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-P. Kovalik, N. Singh, S. K. Mendiratta, W. D. Martin, L. Ignatowicz, and L. Van Kaer
The Alloreactive and Self-Restricted CD4+ T Cell Response Directed Against a Single MHC Class II/Peptide Combination
J. Immunol., August 1, 2000; 165(3): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. A. Zaia, J.G. P. Sissons, S. Riddell, D. J. Diamond, M.R. Wills, A.J. Carmichael, M.P. Weekes, M. Gandhi, C. La Rosa, M. Villacres, et al.
Status of Cytomegalovirus Prevention and Treatment in 2000
Hematology, January 1, 2000; 2000(1): 339 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Garcia-Peydro, A. Paradela, J. R. Lamas, and J. A. Lopez de Castro
Peptide Presentation to an Alloreactive CTL Clone Is Modulated Through Multiple Mechanisms Involving Polymorphic and Conserved Residues in HLA-B27
J. Immunol., December 1, 1999; 163(11): 6060 - 6064.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Montoya and M. Del Val
Intracellular Rate-Limiting Steps in MHC Class I Antigen Processing
J. Immunol., August 15, 1999; 163(4): 1914 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. K. Mendiratta, J.-P. Kovalik, S. Hong, N. Singh, W. D. Martin, and L. Van Kaer
Peptide dependency of alloreactive CD4+ T cell responses
Int. Immunol., March 1, 1999; 11(3): 351 - 360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Munz, R. Obst, W. Osen, S. Stevanovic, and H.-G. Rammensee
Alloreactivity as a Source of High Avidity Peptide-Specific Human CTL
J. Immunol., January 1, 1999; 162(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Paradela, M. Garcia-Peydro, J. Vazquez, D. Rognan, and J. A. Lopez de Castro
The Same Natural Ligand Is Involved in Allorecognition of Multiple HLA-B27 Subtypes by a Single T Cell Clone: Role of Peptide and the MHC Molecule in Alloreactivity
J. Immunol., November 15, 1998; 161(10): 5481 - 5490.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. C. Gil-Torregrosa, A. Raul Castano, and M. Del  Val
Major Histocompatibility Complex Class I Viral Antigen Processing in the Secretory Pathway Defined by the trans-Golgi Network Protease Furin
J. Exp. Med., September 21, 1998; 188(6): 1105 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shi, K. D. Smith, and C. T. Lutz
TAP-Independent MHC Class I Peptide Antigen Presentation to Alloreactive CTL Is Enhanced by Target Cell Incubation at Subphysiologic Temperatures
J. Immunol., May 1, 1998; 160(9): 4305 - 4312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Wang, S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard
Class I-Restricted Alloreactive Cytotoxic T Lymphocytes Recognize a Complex Array of Specific MHC-Associated Peptides
J. Immunol., February 1, 1998; 160(3): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Diamond, J. York, J.-Y. Sun, C. L. Wright, and S. J. Forman
Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection
Blood, September 1, 1997; 90(5): 1751 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P. A. Smith, A. Brunmark, M. R. Jackson, and T. A. Potter
Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)
J. Exp. Med., March 17, 1997; 185(6): 1023 - 1034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.